Back to search

Peptide record

TPDB42632

L11 Anticancer standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42632
L11
Anticancer
Cancer-related peptides
ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF pep-lab
standard
No
A 18-aa standard natural anticancer peptide sequence curated from ACP740 _ACP240, AntiCP 2.0, CancerPPD 2.0, and other sources, with an available 3D structural model.
Sequence
PAARKAARWAWRMLKKGA
Physicochemical Analysis
C94H154N32O19S1
NDCEQHIFSTYV
A
2068.52
12.71
6
0
10
+6
0.35
-0.694
55.00
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
11000
531.78
0
Residue Composition
number
6
A
3
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
1
L
3
K
1
M
0
F
1
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 6 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 1 K: 3 M: 1 F: 0 P: 1 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
18
C94H154N32O19S1
2068.52
12.71
+6
0.35
-0.694
Free
L
Cyclic
Free
Antimicrobial
Lactoferrin
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50=116 µM
Anticancer
116 µM

Target

Skin Cancer
Meth A
Skin

Assay & Model

MTT/MTS assay
4-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2002

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50=75 µM
Anticancer
75 µM

Target

Breast Cancer
MT-1
Breast

Assay & Model

MTT/MTS assay
4-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2002
Evidence 3 Activity

Activity

IC50
IC50=248 µM
Anticancer
248 µM

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT/MTS assay
4-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2002